Literature DB >> 26961978

Family Communication and Cascade Testing for Fragile X Syndrome.

Melissa Raspa1, Anne Edwards2, Anne C Wheeler2, Ellen Bishop3, Donald B Bailey2.   

Abstract

A total of 679 families who had at least one child with fragile X syndrome (FXS) were recruited from a research registry to participate in a survey examining cascade testing and communication about FXS. Families had a total of 1117 children (804 males, 313 females). Most families (84 %) had tested all of their children. The main reason for not testing, which did not differ by gender or age of the child, was that the child did not show signs of FXS (68 %). Families talked with their children about FXS occasionally (47 %) although 16 % said they do not talk about it. Most families (66 %) had told their children their FXS status, with males and those with the premutation being less likely to be told test results. Of those that did not, 46 % said that they would tell their child when they were old enough to understand, whereas 34 % had either decided they would not tell or were not sure if or when they were going to tell. About a quarter of respondents (28 %) indicated that no extended family members had been tested, with income and communication about FXS being the strongest predictors. Results from this large scale survey provide important data on how families communicate about FXS and reasons testing is or is not sought. This information can be used by genetic counsellors in providing follow-up to families after a FXS diagnosis.

Entities:  

Keywords:  Cascade testing; Family communication; Fragile X syndrome; Genetic counseling

Mesh:

Year:  2016        PMID: 26961978     DOI: 10.1007/s10897-016-9940-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  51 in total

1.  Communicating genetic test results to the family: a six-step, skills-building strategy.

Authors:  M B Daly; A Barsevick; S M Miller; R Buckman; J Costalas; S Montgomery; R Bingler
Journal:  Fam Community Health       Date:  2001-10

Review 2.  The behavioral phenotype of FMR1 mutations.

Authors:  Lia Boyle; Walter E Kaufmann
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-11-15       Impact factor: 3.908

Review 3.  Communicating genetic information in families--a review of guidelines and position papers.

Authors:  Laura E Forrest; Martin B Delatycki; Loane Skene; MaryAnne Aitken
Journal:  Eur J Hum Genet       Date:  2007-03-28       Impact factor: 4.246

4.  DNA testing for fragile X syndrome: implications for parents and family.

Authors:  M A van Rijn; B B de Vries; A Tibben; A M van den Ouweland; D J Halley; M F Niermeijer
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

Review 5.  Understanding the molecular basis of fragile X syndrome.

Authors:  P Jin; S T Warren
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

6.  "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.

Authors:  Alison D Archibald; Alice M Jaques; Samantha Wake; Veronica R Collins; Jonathan Cohen; Sylvia A Metcalfe
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

7.  Genetic risk communication: experiences of adolescent girls and young women from families with fragile X syndrome.

Authors:  Allyn McConkie-Rosell; Elizabeth Melvin Heise; Gail A Spiridigliozzi
Journal:  J Genet Couns       Date:  2009-03-11       Impact factor: 2.537

8.  An audit of clinical service examining the uptake of genetic testing by at-risk family members.

Authors:  Laura Forrest; Martin Delatycki; Lisette Curnow; M Gen Couns; Loane Skene; Maryanne Aitken
Journal:  Genet Med       Date:  2012-01       Impact factor: 8.822

9.  Caregiver opinions about fragile X population screening.

Authors:  Donald B Bailey; Ellen Bishop; Melissa Raspa; Debra Skinner
Journal:  Genet Med       Date:  2011-09-13       Impact factor: 8.822

10.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

View more
  4 in total

Review 1.  Barriers and facilitators for cascade testing in genetic conditions: a systematic review.

Authors:  Swetha Srinivasan; Nae Yeon Won; W David Dotson; Sarah T Wright; Megan C Roberts
Journal:  Eur J Hum Genet       Date:  2020-09-18       Impact factor: 4.246

2.  Advancing artificial intelligence-assisted pre-screening for fragile X syndrome.

Authors:  Arezoo Movaghar; David Page; Murray Brilliant; Marsha Mailick
Journal:  BMC Med Inform Decis Mak       Date:  2022-06-10       Impact factor: 3.298

3.  Mindfulness and Acceptance as Potential Protective Factors for Mothers of Children With Fragile X Syndrome.

Authors:  Anne C Wheeler; Shari Miller; Amanda Wylie; Anne Edwards
Journal:  Front Public Health       Date:  2018-11-06

4.  FMR1 premutation frequency in a large, ethnically diverse population referred for carrier testing.

Authors:  Kailey M Owens; Lindsay Dohany; Carol Holland; Jeana DaRe; Tobias Mann; Christina Settler; Ryan E Longman
Journal:  Am J Med Genet A       Date:  2018-03-31       Impact factor: 2.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.